Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dicarboxylic acid esters for the treatment of diseases and conditions associated with phospholipase D toxin

Dicarboxylic acid esters for the treatment of diseases and conditions associated with phospholipase D toxin

US Patent 11918555 · Granted Mar 5, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Azelaic acid esters in the treatment of insulin resistance2025
Azelaic acid esters in the treatment of insulin resistance2025
Dicarboxylic acid esters for inducing an analgesic effect2024
Dicarboxylic acid esters for inducing an analgesic effect2024
Methods of identification, assessment, prevention and therapy of lung diseases a2022
Methods of identification, assessment, prevention and therapy of lung diseases a2022
Azelaic acid esters in the treatment of insulin resistance2021
Azelaic acid esters in the treatment of insulin resistance2021
Azelaic acid esters in the treatment of insulin resistance2019
Azelaic acid esters in the treatment of insulin resistance2019
Methods of identification and diagnosis of lung diseases using classification sy2018
Methods of identification and diagnosis of lung diseases using classification sy2018